Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer

被引:163
|
作者
Liu, HH
Wang, XC
Dong, L
Wu, QW
Liao, ZX
Stevens, CW
Guerrero, TM
Komaki, R
Cox, JD
Mohan, R
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA USA
关键词
intensity-modulated radiotherapy; non-small-cell lung cancer; integral dose; low-dose volumes; lung toxicity;
D O I
10.1016/j.ijrobp.2003.09.085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the possibility of using intensity-modulated radiotherapy (IMRT) to reduce the irradiated volumes of the normal lung and other critical structures in the treatment of non-small-cell lung cancer (NSCLC) and to investigate the effect of IMRT on the potential of spreading low doses to large volumes of normal tissues in such treatment. Methods and Materials: A retrospective treatment planning study was performed to compare IMRT and conventional three-dimensional conformal radiation therapy (3D-CRT) for 10 NSCLC patients (Stage I-IIIB). In the IMRT plans, three to nine coplanar beams were designed to treat 95% of the planning target volume with 63 Gy and to minimize the volumes of the normal lung, esophagus, heart, and spinal cord irradiated above their tolerance doses. The two types of plans were compared with respect to the planning target volume coverage, dose-volume histograms, and other dosimetric indexes of the normal structures. Results: Comparing the nine-beam IMRT plan with the 3D-CRT plan, the percentage of lung volume that received >20 Gy and the mean lung dose were reduced for all cases, with a median reduction of 8% and 2 Gy, respectively. An additional reduction of the >5-Gy volume and >10-Gy volume for the lung and thoracic tissue was more difficult with IMRT, although still possible using fewer beams in IMRT. The integral dose to the entire thorax was equivalent and even reduced for 8 of 10 cases using IMRT. Conclusion: It is possible to reduce the volumes of low doses (such as the >10-Gy volume and >20-Gy volume) for thoracic normal tissues using IMRT. The increased integral dose and low-dose volumes can be avoided for IMRT if such concerns are addressed carefully in the inverse planning process and with optimization of the IMRT beam configuration. (C) 2004 Elsevier Inc.
引用
收藏
页码:1268 / 1279
页数:12
相关论文
共 50 条
  • [41] Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer
    Liao, Zhongxing
    Lee, J. Jack
    Komaki, Ritsuko
    Gomez, Daniel R.
    O'Reilly, Michael S.
    Fossella, Frank V.
    Blumenschein, George R., Jr.
    Heymach, John V.
    Vaporciyan, Ara A.
    Swisher, Stephen G.
    Allen, Pamela K.
    Choi, Noah Chan
    DeLaney, Thomas F.
    Hahn, Stephen M.
    Cox, James D.
    Lu, Charles S.
    Mohan, Radhe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1813 - +
  • [42] Routine Use of Intensity-Modulated Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Is Neither Choosing Wisely Nor Personalized Medicine Reply
    Chun, Stephen G.
    Hu, Chen
    Bradley, Jeffrey D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (13) : 1493 - +
  • [43] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) - a feasibility study
    Faivre-Finn, C.
    Falk, S.
    Franks, K.
    Hanna, G.
    Harden, S.
    Harrow, S.
    Hatton, M. Q.
    McDonald, F.
    LUNG CANCER, 2015, 87 : S51 - S51
  • [44] Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) - a feasibility study
    Groom, N.
    Tsang, Y.
    Hatton, M.
    Hanna, G. G.
    Franks, K.
    Hardens, S.
    Mcdonald, F.
    Harrow, S.
    Faivre-Finn, C.
    LUNG CANCER, 2016, 91 : S69 - S70
  • [45] Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
    Yang, Eunyeong
    Shin, Young Seob
    Joo, Ji Hyeon
    Choi, Wonsik
    Kim, Su Ssan
    Choi, Eun Kyung
    Lee, Jaeha
    Song, Si Yeol
    RADIATION ONCOLOGY JOURNAL, 2023, 41 (03): : 199 - 208
  • [46] Isotoxic radiotherapy for non-small cell lung cancer: is intensity modulated radiotherapy (IMRT) the answer?
    Warren, M.
    Webster, G.
    Faivre-Finn, C.
    Rowbottom, C.
    LUNG CANCER, 2013, 79 : S55 - S55
  • [47] Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy
    Cai, Shuhua
    Shi, Anhui
    Yu, Rong
    Zhu, Guangying
    RADIATION ONCOLOGY, 2014, 9
  • [48] Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
    Abe, Takanori
    Iino, Misaki
    Saito, Satoshi
    Aoshika, Tomomi
    Ryuno, Yasuhiro
    Ohta, Tomohiro
    Igari, Mitsunobu
    Hirai, Ryuta
    Kumazaki, Yu
    Miura, Yu
    Kaira, Kyoichi
    Kagamu, Hiroshi
    Noda, Shin-ei
    Kato, Shingo
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (05) : 894 - 900
  • [49] Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy
    Shuhua Cai
    Anhui Shi
    Rong Yu
    Guangying Zhu
    Radiation Oncology, 9
  • [50] Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy
    Liang, Xiangcun
    Yu, Huiming
    Yu, Rong
    Xu, Gang
    Zhu, Guangying
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1172 - 1176